Sight Sciences’ TearCare Shows Lasting Dry Eye Relief in Sahara Phase III Trial
Latest data shows TearCare delivers nearly two years of sustained dry eye relief after only two treatments. The Phase III…
Alcon Launches TRYPTYR in U.S. for Dry Eye Disease Treatment
TRYPTYR (acoltremon ophthalmic solution 0.003%) stimulates tear production via TRPM8 activation and is now available in the U.S. An intriguing…
latest posts
